| 产品标题 |
产品货号 |
产品规格 |
厂家 |
| Bcas3 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN502084 | 1 kit | ORIGENE TECHNOLOGIES |
| BCAS3 Mass Spectrometry Standard from ORIGENE TECHNOLOGIES | PH317085 | 10 ug | ORIGENE TECHNOLOGIES |
| BCAS4 Mass Spectrometry Standard from ORIGENE TECHNOLOGIES | PH318580 | 10 ug | ORIGENE TECHNOLOGIES |
| BCAT2 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN400625 | 1 kit | ORIGENE TECHNOLOGIES |
| BCAT1 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN419229 | 1 kit | ORIGENE TECHNOLOGIES |
| BCAS2 Mass Spectrometry Standard from ORIGENE TECHNOLOGIES | PH305615 | 10 ug | ORIGENE TECHNOLOGIES |
| BCAS4 Mass Spectrometry Standard from ORIGENE TECHNOLOGIES | PH315772 | 10 ug | ORIGENE TECHNOLOGIES |
| Bcat1 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN502085 | 1 kit | ORIGENE TECHNOLOGIES |
| BCAT1 Mass Spectrometry Standard from ORIGENE TECHNOLOGIES | PH319229 | 10 ug | ORIGENE TECHNOLOGIES |
| Bcat2 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN502086 | 1 kit | ORIGENE TECHNOLOGIES |
| BCAT2 Mass Spectrometry Standard from ORIGENE TECHNOLOGIES | PH300625 | 10 ug | ORIGENE TECHNOLOGIES |
| BCCIP - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN403061 | 1 kit | ORIGENE TECHNOLOGIES |
| Human Tongue; Carcinoma of tongue, squamous cell, metastatic from ORIGENE TECHNOLOGIES | CS708375 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Tongue; Carcinoma of tongue, squamous cell, metastatic from ORIGENE TECHNOLOGIES | CS708376 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Tongue; Carcinoma of tongue, squamous cell, metastatic from ORIGENE TECHNOLOGIES | CS708379 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Tongue; Carcinoma of tongue, squamous cell, metastatic from ORIGENE TECHNOLOGIES | CS529485 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Tongue; Carcinoma of tongue, squamous cell, metastatic from ORIGENE TECHNOLOGIES | CS709582 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Tongue; Carcinoma of tongue, squamous cell, metastatic from ORIGENE TECHNOLOGIES | CS709581 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Tonsil; Follicular hyperplasia of tonsil from ORIGENE TECHNOLOGIES | CS704898 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Tonsil; Follicular hyperplasia of tonsil from ORIGENE TECHNOLOGIES | CS600845 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Tonsil; Follicular hyperplasia of tonsil from ORIGENE TECHNOLOGIES | CS706603 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Tonsil; Follicular hyperplasia of tonsil from ORIGENE TECHNOLOGIES | CS524019 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Tonsil; Follicular hyperplasia of tonsil from ORIGENE TECHNOLOGIES | CS601076 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Tonsil; Follicular hyperplasia of tonsil from ORIGENE TECHNOLOGIES | CS601103 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Tonsil; Follicular hyperplasia of tonsil from ORIGENE TECHNOLOGIES | CS601104 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Tonsil; Follicular hyperplasia of tonsil from ORIGENE TECHNOLOGIES | CS601105 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Tonsil; Follicular hyperplasia of tonsil from ORIGENE TECHNOLOGIES | CS601101 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Tonsil; Follicular hyperplasia of tonsil from ORIGENE TECHNOLOGIES | CS601298 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Tonsil; Lymphoid hyperplasia of tonsil from ORIGENE TECHNOLOGIES | CS604303 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Tonsil; Lymphoid hyperplasia of tonsil from ORIGENE TECHNOLOGIES | CS605055 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Tonsil; Follicular hyperplasia of tonsil from ORIGENE TECHNOLOGIES | CS602876 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Tonsil; Follicular hyperplasia of tonsil from ORIGENE TECHNOLOGIES | CS603190 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Tonsil; Lymphoid hyperplasia of tonsil from ORIGENE TECHNOLOGIES | CS605056 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Tonsil; Lymphoid hyperplasia of tonsil from ORIGENE TECHNOLOGIES | CS605058 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Tonsil; Lymphoid hyperplasia of tonsil from ORIGENE TECHNOLOGIES | CS605057 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Tonsil; Lymphoid hyperplasia of tonsil from ORIGENE TECHNOLOGIES | CS605059 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Tonsil; Lymphoid hyperplasia of tonsil from ORIGENE TECHNOLOGIES | CS605060 | 5x5um | ORIGENE TECHNOLOGIES |
| Makorin ring finger protein 2 (MKRN2) from ORIGENE TECHNOLOGIES | LY415468 | 100 ug | ORIGENE TECHNOLOGIES |
| Makorin ring finger protein 1 (MKRN1), transcript variant 1 from ORIGENE TECHNOLOGIES | LY415580 | 100 ug | ORIGENE TECHNOLOGIES |
| Makorin ring finger protein 1 (MKRN1), transcript variant 2 from ORIGENE TECHNOLOGIES | LY428707 | 100 ug | ORIGENE TECHNOLOGIES |
| Malate dehydrogenase 1B, NAD (soluble) (MDH1B) from ORIGENE TECHNOLOGIES | LY421838 | 100 ug | ORIGENE TECHNOLOGIES |
| Malate dehydrogenase 2, NAD (mitochondrial) (MDH2), nuclear gene encoding mitochondrial protein from ORIGENE TECHNOLOGIES | LY401789 | 100 ug | ORIGENE TECHNOLOGIES |
| Malate dehydrogenase 1, NAD (soluble) (MDH1), transcript variant 1 from ORIGENE TECHNOLOGIES | LY434177 | 100 ug | ORIGENE TECHNOLOGIES |
| Malectin (MLEC) from ORIGENE TECHNOLOGIES | LY415102 | 100 ug | ORIGENE TECHNOLOGIES |
| Malate dehydrogenase 1, NAD (soluble) (MDH1) from ORIGENE TECHNOLOGIES | LY401788 | 100 ug | ORIGENE TECHNOLOGIES |
| Male-enhanced antigen 1 (MEA1) from ORIGENE TECHNOLOGIES | LY415154 | 100 ug | ORIGENE TECHNOLOGIES |
| Male-specific lethal 1 homolog (Drosophila) (MSL1) from ORIGENE TECHNOLOGIES | LY423311 | 100 ug | ORIGENE TECHNOLOGIES |
| Male-specific lethal 3 homolog (Drosophila) (MSL3), transcript variant 1 from ORIGENE TECHNOLOGIES | LY409198 | 100 ug | ORIGENE TECHNOLOGIES |
| Male-specific lethal 2 homolog (Drosophila) (MSL2), transcript variant 1 from ORIGENE TECHNOLOGIES | LY413286 | 100 ug | ORIGENE TECHNOLOGIES |
| Male-specific lethal 3 homolog (Drosophila) (MSL3), transcript variant 1 from ORIGENE TECHNOLOGIES | LY429934 | 100 ug | ORIGENE TECHNOLOGIES |